A nurse is speaking with the caregiver of a client who has Alzheimer’s disease. The caregiver states, “Providing constant care is very stressful and is affecting all areas of my life.” Which of the following actions should the nurse take?

Choice A reason: Discussing communication methods addresses client behaviors but not the caregiver’s stress from constant care. A daycare program offers respite. Focusing on communication risks neglecting caregiver well-being, potentially worsening burnout, critical to avoid in supporting caregivers of Alzheimer’s clients with high care demands.

Choice B reason: Suggesting antipsychotics for the client addresses behavior but not caregiver stress, and is inappropriate without medical evaluation. Daycare provides relief. Assuming medication is the solution risks unnecessary drug use, potentially causing side effects, critical to avoid in supporting caregiver health and client safety.

Choice C reason: Allowing the client time alone is unsafe for Alzheimer’s patients due to wandering risks and does not relieve caregiver stress. Daycare is effective. Assuming alone time helps risks client safety and caregiver burden, critical to prevent in ensuring comprehensive care for Alzheimer’s clients and caregivers.

Choice D reason: Assisting with a daycare program provides respite, reducing caregiver stress and preventing burnout while ensuring client safety. This intervention supports caregiver well-being, critical for sustained care quality, promoting mental health, and enabling effective management of Alzheimer’s disease in home settings with high care demands.

Choice A reason: Protamine sulfate reverses heparin, not midazolam, a benzodiazepine requiring flumazenil for reversal. Assuming protamine is needed risks ineffective response to oversedation, critical to avoid in ensuring rapid reversal and safety in clients post-moderate sedation with midazolam in surgical settings.

Choice B reason: Acetylcysteine treats acetaminophen overdose, not midazolam, reversed by flumazenil. Assuming acetylcysteine is appropriate risks delayed reversal of sedation, potentially causing respiratory depression, critical to prevent in ensuring safe recovery for clients post-moderate sedation with midazolam in postoperative care.

Choice C reason: Flumazenil reverses midazolam’s benzodiazepine effects, critical for managing oversedation or respiratory depression post-moderate sedation. Having it on hand ensures rapid response, essential for client safety, preventing complications, and supporting recovery in surgical settings using midazolam for procedural sedation.

Choice D reason: Naloxone reverses opioids, not midazolam, a benzodiazepine requiring flumazenil. Assuming naloxone is needed risks ineffective treatment of sedation, potentially prolonging respiratory risks, critical to avoid in ensuring proper reversal and safety in clients post-moderate sedation with midazolam.